| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 2.47e-13 | 431 | 153 | 23 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 OR5J2 P2RY1 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 5.13e-12 | 884 | 153 | 30 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 CHRNA1 CHRNB4 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 OR5J2 PTPRB P2RX5 P2RY1 PTPRZ1 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.32e-10 | 1353 | 153 | 35 | GO:0004888 |
| GeneOntologyMolecularFunction | odorant binding | 6.14e-06 | 127 | 153 | 8 | GO:0005549 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.51e-05 | 7 | 153 | 3 | GO:0004985 | |
| GeneOntologyMolecularFunction | transporter activity | SLC25A24 SFXN4 CACNA1S ATP13A1 ESYT1 ATP13A5 SLC1A1 CHRNA1 RYR3 CHRNB4 OPRM1 SLC10A1 CLCN6 P2RX5 SLC15A1 GET3 PITPNM3 KCNQ2 SLC13A5 CACNA1I ABCC12 ATP11A SLC25A23 UNC80 | 4.60e-05 | 1289 | 153 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | ADP:phosphate antiporter activity | 5.83e-05 | 2 | 153 | 2 | GO:0140988 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 5.83e-05 | 2 | 153 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 5.83e-05 | 2 | 153 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 SPG7 MYO9A ATP13A1 ATP13A5 YTHDC2 MORC4 DNAH12 GET3 UBA6 SMARCA4 ABCC12 ATP11A MYO15A DDX28 | 7.76e-05 | 614 | 153 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SFXN4 CACNA1S ATP13A1 ATP13A5 SLC1A1 CHRNA1 RYR3 CHRNB4 OPRM1 SLC10A1 CLCN6 P2RX5 SLC15A1 KCNQ2 SLC13A5 CACNA1I UNC80 | 1.26e-04 | 793 | 153 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | aromatase activity | 1.44e-04 | 35 | 153 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | ATP:phosphate antiporter activity | 1.74e-04 | 3 | 153 | 2 | GO:0140987 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1S ATP13A1 ATP13A5 SLC1A1 CHRNA1 RYR3 CHRNB4 OPRM1 SLC10A1 P2RX5 SLC15A1 KCNQ2 SLC13A5 CACNA1I UNC80 | 1.83e-04 | 664 | 153 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC25A24 SFXN4 CACNA1S ATP13A1 ATP13A5 SLC1A1 CHRNA1 RYR3 CHRNB4 OPRM1 SLC10A1 CLCN6 P2RX5 SLC15A1 GET3 KCNQ2 SLC13A5 CACNA1I ABCC12 SLC25A23 UNC80 | 2.67e-04 | 1180 | 153 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 5.37e-04 | 49 | 153 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 5.75e-04 | 5 | 153 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | SPG7 ATP13A1 ATP13A5 YTHDC2 MORC4 DNAH12 GET3 SMARCA4 ABCC12 ATP11A DDX28 | 6.06e-04 | 441 | 153 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 7.53e-04 | 194 | 153 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 7.93e-04 | 24 | 153 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1S SLC1A1 CHRNA1 RYR3 CHRNB4 OPRM1 CLCN6 P2RX5 KCNQ2 CACNA1I UNC80 | 8.41e-04 | 459 | 153 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | 1.12e-03 | 334 | 153 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.13e-03 | 27 | 153 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | organophosphate:phosphate antiporter activity | 1.19e-03 | 7 | 153 | 2 | GO:0015315 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.19e-03 | 7 | 153 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.19e-03 | 7 | 153 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.34e-03 | 343 | 153 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC25A24 CACNA1S ATP13A1 SLC1A1 RYR3 OPRM1 SLC10A1 CLCN6 SLC15A1 GET3 KCNQ2 SLC13A5 CACNA1I SLC25A23 | 2.11e-03 | 758 | 153 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.41e-03 | 35 | 153 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 2.41e-03 | 35 | 153 | 3 | GO:0033612 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1S SLC1A1 CHRNA1 RYR3 CHRNB4 OPRM1 CLCN6 P2RX5 KCNQ2 CACNA1I UNC80 | 2.44e-03 | 525 | 153 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1S SLC1A1 CHRNA1 RYR3 CHRNB4 OPRM1 CLCN6 P2RX5 KCNQ2 CACNA1I UNC80 | 2.47e-03 | 526 | 153 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 2.52e-03 | 10 | 153 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 2.52e-03 | 10 | 153 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 2.52e-03 | 10 | 153 | 2 | GO:0008641 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 2.52e-03 | 10 | 153 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.82e-03 | 182 | 153 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.83e-03 | 37 | 153 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.98e-03 | 184 | 153 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 3.07e-03 | 11 | 153 | 2 | GO:0015217 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.00e-13 | 432 | 151 | 23 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.36e-13 | 485 | 151 | 24 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception | OR8U1 OR9A4 OR5AK2 DHRS3 OR4S2 MYO9A OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 OR52I2 ATF6 ABLIM1 OR5J2 OR1A1 TAS1R2 KCNQ2 OR4C12 OR52M1 OR2V2 MYO15A TBX1 CLRN2 OR4F6 OR1L4 | 2.72e-13 | 1072 | 151 | 34 | GO:0007600 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 4.64e-13 | 465 | 151 | 23 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 7.16e-13 | 524 | 151 | 24 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.79e-12 | 547 | 151 | 24 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 6.61e-12 | 582 | 151 | 24 | GO:0050906 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 SLC1A1 ADCY2 PREX2 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 NLN OR5J2 P2RY1 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 3.63e-10 | 1395 | 151 | 34 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 5.48e-10 | 722 | 151 | 24 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SFXN4 CACNA1S RELN NEDD4L SPG7 ATP13A1 ATP13A5 SLC1A1 CHRNA1 RYR3 CHRNB4 OPRK1 OPRM1 LHCGR CLCN6 P2RX5 SLC15A1 KCNQ2 SLC13A5 CACNA1I SLC25A23 UNC80 PCYOX1 | 6.51e-06 | 1115 | 151 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SFXN4 CACNA1S RELN NEDD4L SPG7 ATP13A1 ATP13A5 SLC1A1 CHRNA1 RYR3 CHRNB4 OPRD1 OPRK1 OPRM1 LHCGR SLC10A1 CLCN6 P2RX5 P2RY1 SLC15A1 KCNQ2 SLC13A5 CACNA1I SLC25A23 UNC80 PCYOX1 | 7.14e-06 | 1374 | 151 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 3.13e-05 | 9 | 151 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | eating behavior | 5.56e-05 | 56 | 151 | 5 | GO:0042755 | |
| GeneOntologyBiologicalProcess | response to nicotine | 6.60e-05 | 58 | 151 | 5 | GO:0035094 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 1.04e-04 | 13 | 151 | 3 | GO:0038003 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.32e-04 | 14 | 151 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting opioid receptor signaling pathway | 1.59e-04 | 3 | 151 | 2 | GO:0031635 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 1.59e-04 | 3 | 151 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 2.05e-04 | 40 | 151 | 4 | GO:0071312 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 2.52e-04 | 284 | 151 | 9 | GO:0007626 | |
| GeneOntologyBiologicalProcess | glial cell migration | 3.04e-04 | 80 | 151 | 5 | GO:0008347 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1S NEDD4L SPG7 ATP13A1 ATP13A5 SLC1A1 CHRNA1 RYR3 OPRD1 OPRK1 OPRM1 LHCGR SLC10A1 P2RX5 SLC15A1 KCNQ2 SLC13A5 CACNA1I SLC25A23 UNC80 | 3.05e-04 | 1157 | 151 | 20 | GO:0006812 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 4.25e-04 | 86 | 151 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 4.28e-04 | 132 | 151 | 6 | GO:0043255 | |
| Domain | GPCR_Rhodpsn_7TM | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 OR5J2 P2RY1 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 8.48e-13 | 670 | 152 | 28 | IPR017452 |
| Domain | Olfact_rcpt | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.06e-12 | 393 | 152 | 22 | IPR000725 |
| Domain | 7tm_1 | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 OR5J2 P2RY1 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.09e-12 | 677 | 152 | 28 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 OR5J2 P2RY1 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.45e-12 | 685 | 152 | 28 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 OR5J2 P2RY1 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.78e-12 | 691 | 152 | 28 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OPRD1 OPRK1 OR8U8 OPRM1 OR10A3 OR2T3 LHCGR GPR161 OR52I2 OR5J2 P2RY1 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.84e-12 | 692 | 152 | 28 | IPR000276 |
| Domain | Opioid_rcpt | 2.10e-06 | 4 | 152 | 3 | IPR001418 | |
| Domain | Fam133 | 6.58e-05 | 2 | 152 | 2 | IPR026766 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 9.76e-12 | 417 | 123 | 22 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.99e-11 | 389 | 123 | 21 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8U1 OR9A4 OR5AK2 DHRS3 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR8U9 OR8U8 OR10A3 OR2T3 OR52I2 OR5J2 OR1A1 TAS1R2 OR4C12 OR52M1 OR2V2 MYO15A OR4F6 OR1L4 | 1.84e-10 | 636 | 123 | 25 | M41834 |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.86e-04 | 33 | 123 | 4 | MM1448 | |
| Pathway | WP_GPCRS_OTHER | 1.91e-04 | 96 | 123 | 6 | MM15939 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 2.09e-04 | 34 | 123 | 4 | M16393 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.36e-04 | 64 | 123 | 5 | M9488 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.73e-04 | 15 | 123 | 3 | M39717 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.59e-04 | 70 | 123 | 5 | MM14984 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.54e-04 | 260 | 123 | 9 | M39397 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 4.81e-04 | 18 | 123 | 3 | MM14843 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 4.81e-04 | 18 | 123 | 3 | M27901 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR5M8 OR10A3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.12e-15 | 340 | 154 | 19 | 11875048 |
| Pubmed | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR5M8 OR10A3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.12e-15 | 340 | 154 | 19 | 11802173 | |
| Pubmed | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR5M8 OR10A3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.32e-15 | 343 | 154 | 19 | 32295537 | |
| Pubmed | OR8U1 OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR5AK3P OR1A2 OR8U3 OR5M8 OR10A3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 1.55e-15 | 346 | 154 | 19 | 14611657 | |
| Pubmed | OR9A4 OR5AK2 OR4S2 OR13C8 OR2W1 OR1A2 OR8U3 OR2T34 OR5M8 OR10A3 OR52I2 OR5J2 OR1A1 OR4C12 OR52M1 OR2V2 OR4F6 OR1L4 | 4.02e-11 | 541 | 154 | 18 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR4S2 OR13C8 OR2W1 OR1A2 OR2T34 OR5M8 OR10A3 OR1A1 OR4C12 OR2V2 OR1L4 | 4.38e-09 | 219 | 154 | 11 | 12213199 |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 10082819 | ||
| Pubmed | Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. | 8.51e-08 | 3 | 154 | 3 | 18537939 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 12603260 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 15178356 | ||
| Pubmed | Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | 8.51e-08 | 3 | 154 | 3 | 8114680 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 11032994 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 25855262 | ||
| Pubmed | Opioid receptors: from binding sites to visible molecules in vivo. | 8.51e-08 | 3 | 154 | 3 | 18718480 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 18213616 | ||
| Pubmed | Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. | 8.51e-08 | 3 | 154 | 3 | 11069979 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 19032295 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 15090050 | ||
| Pubmed | Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. | 8.51e-08 | 3 | 154 | 3 | 18338799 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 17676326 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 26692286 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 17374034 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 11504820 | ||
| Pubmed | Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. | 8.51e-08 | 3 | 154 | 3 | 12431223 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 28049031 | ||
| Pubmed | Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms. | 8.51e-08 | 3 | 154 | 3 | 26946441 | |
| Pubmed | Nociception increases during opioid infusion in opioid receptor triple knock-out mice. | 8.51e-08 | 3 | 154 | 3 | 17544222 | |
| Pubmed | Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. | 8.51e-08 | 3 | 154 | 3 | 14745298 | |
| Pubmed | Opioid receptor characterisation of neuronally stimulated isolated human vas deferens. | 8.51e-08 | 3 | 154 | 3 | 22752269 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 24874714 | ||
| Pubmed | Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. | 8.51e-08 | 3 | 154 | 3 | 11826143 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 33555255 | ||
| Pubmed | Enhanced humoral response in kappa-opioid receptor knockout mice. | 8.51e-08 | 3 | 154 | 3 | 12507774 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 14975676 | ||
| Pubmed | Identification of ligands for olfactory receptors by functional expression of a receptor library. | 1.78e-07 | 12 | 154 | 4 | 9875846 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 12413885 | ||
| Pubmed | Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. | 3.39e-07 | 4 | 154 | 3 | 9502813 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 11430857 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 30249798 | ||
| Pubmed | Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. | 3.39e-07 | 4 | 154 | 3 | 8941707 | |
| Pubmed | Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. | 3.39e-07 | 4 | 154 | 3 | 10049703 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 16053916 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 33782947 | ||
| Pubmed | Variations in opioid receptor genes in neonatal abstinence syndrome. | 8.46e-07 | 5 | 154 | 3 | 26233486 | |
| Pubmed | Genetic susceptibility to heroin addiction: a candidate gene association study. | 1.69e-06 | 6 | 154 | 3 | 18518925 | |
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 12044478 | ||
| Pubmed | Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. | 1.69e-06 | 6 | 154 | 3 | 9746745 | |
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 12958197 | ||
| Pubmed | HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | 3.13e-06 | 90 | 154 | 6 | 35671810 | |
| Pubmed | Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. | 4.69e-06 | 8 | 154 | 3 | 18488193 | |
| Pubmed | Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. | 4.69e-06 | 8 | 154 | 3 | 24855103 | |
| Pubmed | UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. | 7.01e-06 | 9 | 154 | 3 | 23028370 | |
| Pubmed | 7.01e-06 | 9 | 154 | 3 | 7678494 | ||
| Pubmed | Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. | 1.95e-05 | 2 | 154 | 2 | 19524516 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15611369 | ||
| Pubmed | Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents. | 1.95e-05 | 2 | 154 | 2 | 31815916 | |
| Pubmed | Differential involvement of the mu and kappa opioid receptors in spatial learning. | 1.95e-05 | 2 | 154 | 2 | 12884965 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28512665 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23965295 | ||
| Pubmed | Association Between Genetic Polymorphisms and Pain Sensitivity in Patients with Hip Osteoarthritis. | 1.95e-05 | 2 | 154 | 2 | 29055075 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11076532 | ||
| Pubmed | An H-YDb epitope is encoded by a novel mouse Y chromosome gene. | 1.95e-05 | 2 | 154 | 2 | 8944031 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23836900 | ||
| Pubmed | Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. | 1.95e-05 | 2 | 154 | 2 | 8393575 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24278116 | ||
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 1.95e-05 | 2 | 154 | 2 | 23641057 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11316510 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28912346 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24413902 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15262338 | ||
| Pubmed | Increased abundance of opioid receptor heteromers after chronic morphine administration. | 1.95e-05 | 2 | 154 | 2 | 20647592 | |
| Pubmed | Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity. | 1.95e-05 | 2 | 154 | 2 | 8930374 | |
| Pubmed | Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. | 1.95e-05 | 2 | 154 | 2 | 24651466 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17622222 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23076834 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 8031839 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23073238 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10860550 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 10835636 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21361347 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 22302826 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17373650 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 1.95e-05 | 2 | 154 | 2 | 11320253 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 14622224 | ||
| Pubmed | Structural determinants of odorant recognition by the human olfactory receptors OR1A1 and OR1A2. | 1.95e-05 | 2 | 154 | 2 | 17601748 | |
| Pubmed | Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. | 1.95e-05 | 2 | 154 | 2 | 17119944 | |
| Pubmed | Mu and delta opioid receptor knockout mice show increased colonic sensitivity. | 1.95e-05 | 2 | 154 | 2 | 27748566 | |
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 1.95e-05 | 2 | 154 | 2 | 12464262 | |
| Pubmed | Ligand directed signaling differences between rodent and human κ-opioid receptors. | 1.95e-05 | 2 | 154 | 2 | 23086943 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 18455254 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23530020 | ||
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 1.95e-05 | 2 | 154 | 2 | 15066132 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19357247 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15657030 | ||
| Pubmed | Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. | 1.95e-05 | 2 | 154 | 2 | 20615975 | |
| Pubmed | Distribution of delta and mu opioid receptor mRNA in rodent dorsal root ganglia neurons. | 1.95e-05 | 2 | 154 | 2 | 35674691 | |
| Pubmed | κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. | 1.95e-05 | 2 | 154 | 2 | 31940240 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 16331961 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23825080 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23313934 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.76e-04 | 345 | 154 | 7 | chr11q12 | |
| Cytoband | 11q12.1 | 2.21e-04 | 161 | 154 | 5 | 11q12.1 | |
| Cytoband | 11q11 | 5.39e-04 | 47 | 154 | 3 | 11q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q21 | 6.67e-04 | 205 | 154 | 5 | chr18q21 | |
| GeneFamily | Opioid receptors | 8.73e-07 | 4 | 110 | 3 | 245 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 3.62e-04 | 5 | 110 | 2 | 1213 | |
| GeneFamily | Olfactory receptors, family 5 | 6.09e-04 | 112 | 110 | 5 | 152 | |
| GeneFamily | Serpin peptidase inhibitors | 1.46e-03 | 37 | 110 | 3 | 739 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.60e-03 | 10 | 110 | 2 | 100 | |
| GeneFamily | Olfactory receptors, family 1 | 1.84e-03 | 40 | 110 | 3 | 147 | |
| GeneFamily | Olfactory receptors, family 8 | 3.29e-03 | 49 | 110 | 3 | 155 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 4.16e-03 | 16 | 110 | 2 | 173 | |
| GeneFamily | Olfactory receptors, family 2 | 5.02e-03 | 113 | 110 | 4 | 149 | |
| GeneFamily | T-boxes | 5.27e-03 | 18 | 110 | 2 | 766 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-06 | 187 | 151 | 7 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.69e-06 | 188 | 151 | 7 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.10e-06 | 191 | 151 | 7 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.37e-06 | 199 | 151 | 7 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.37e-06 | 199 | 151 | 7 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.55e-06 | 200 | 151 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 8.04e-06 | 139 | 151 | 6 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.09e-06 | 142 | 151 | 6 | 5690eee2ce1ecd02e34eac4193578bd13c4228b9 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 160 | 151 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 160 | 151 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 169 | 151 | 6 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 170 | 151 | 6 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.58e-05 | 181 | 151 | 6 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.81e-05 | 183 | 151 | 6 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.81e-05 | 183 | 151 | 6 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 186 | 151 | 6 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.30e-05 | 187 | 151 | 6 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 4.56e-05 | 189 | 151 | 6 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.70e-05 | 190 | 151 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.84e-05 | 191 | 151 | 6 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 4.84e-05 | 191 | 151 | 6 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-05 | 193 | 151 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 5.12e-05 | 193 | 151 | 6 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.12e-05 | 193 | 151 | 6 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 5.27e-05 | 194 | 151 | 6 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.27e-05 | 194 | 151 | 6 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.35e-05 | 119 | 151 | 5 | e868453c02dcf0e07821886b81ca739887d43c67 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.43e-05 | 195 | 151 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.43e-05 | 195 | 151 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.58e-05 | 196 | 151 | 6 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.58e-05 | 196 | 151 | 6 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.74e-05 | 197 | 151 | 6 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | severe-Plasmablast|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.91e-05 | 198 | 151 | 6 | 0b1620ad4352ee5d599a72931aaceab4ca407498 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.07e-05 | 199 | 151 | 6 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 6.24e-05 | 200 | 151 | 6 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-05 | 200 | 151 | 6 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-05 | 200 | 151 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.24e-05 | 200 | 151 | 6 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.24e-05 | 200 | 151 | 6 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.24e-05 | 200 | 151 | 6 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-05 | 200 | 151 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.24e-05 | 200 | 151 | 6 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.76e-05 | 125 | 151 | 5 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.85e-05 | 129 | 151 | 5 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tfh|GI_small-bowel / Manually curated celltypes from each tissue | 9.39e-05 | 134 | 151 | 5 | bf94ce5edde8912a27010e229c313d8102d6de62 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tfr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.41e-05 | 70 | 151 | 4 | 125f8e8fcd14420dff5b18f2270516d5baafd38e | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 136 | 151 | 5 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-04 | 143 | 151 | 5 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.32e-04 | 144 | 151 | 5 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.36e-04 | 145 | 151 | 5 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| Drug | NSC117862 | 4.17e-08 | 30 | 152 | 6 | CID000003648 | |
| Drug | Dextrorphan | 6.58e-08 | 7 | 152 | 4 | ctd:D003917 | |
| Drug | AC1L1ILY | 1.86e-07 | 38 | 152 | 6 | CID000004635 | |
| Drug | TRK 820 | 2.92e-07 | 3 | 152 | 3 | ctd:C111212 | |
| Drug | Oxycodone | 2.92e-07 | 3 | 152 | 3 | DB00497 | |
| Drug | Hydromorphone | 2.92e-07 | 3 | 152 | 3 | DB00327 | |
| Drug | Codeine | 2.92e-07 | 3 | 152 | 3 | DB00318 | |
| Drug | Carfentanil | 2.92e-07 | 3 | 152 | 3 | DB01535 | |
| Drug | Morphine | 2.92e-07 | 3 | 152 | 3 | DB00295 | |
| Drug | Hydrocodone | 2.92e-07 | 3 | 152 | 3 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 2.92e-07 | 3 | 152 | 3 | DB01571 | |
| Drug | Heroin | 2.92e-07 | 3 | 152 | 3 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 2.92e-07 | 3 | 152 | 3 | DB01439 | |
| Drug | morphine-7,8-oxide | 2.92e-07 | 3 | 152 | 3 | CID005491901 | |
| Drug | Levorphanol | 2.92e-07 | 3 | 152 | 3 | ctd:D007981 | |
| Drug | Levallorphan | 2.92e-07 | 3 | 152 | 3 | ctd:D007977 | |
| Drug | Buprenorphine | 2.92e-07 | 3 | 152 | 3 | DB00921 | |
| Drug | Levorphanol | 2.92e-07 | 3 | 152 | 3 | DB00854 | |
| Drug | Remifentanil | 2.92e-07 | 3 | 152 | 3 | DB00899 | |
| Drug | Nalbuphine | 2.92e-07 | 3 | 152 | 3 | DB00844 | |
| Drug | Fentanyl | 2.92e-07 | 3 | 152 | 3 | DB00813 | |
| Drug | Sufentanil | 2.92e-07 | 3 | 152 | 3 | DB00708 | |
| Drug | Propoxyphene | 2.92e-07 | 3 | 152 | 3 | DB00647 | |
| Drug | Butorphanol | 2.92e-07 | 3 | 152 | 3 | DB00611 | |
| Drug | Butorphanol | 2.92e-07 | 3 | 152 | 3 | ctd:D002077 | |
| Drug | cyclorphan | 2.92e-07 | 3 | 152 | 3 | ctd:C084603 | |
| Drug | Alvimopan | 2.92e-07 | 3 | 152 | 3 | DB06274 | |
| Drug | dextrallorphan | 2.92e-07 | 3 | 152 | 3 | ctd:C044130 | |
| Drug | 14-phenylpropoxymetopon | 2.92e-07 | 3 | 152 | 3 | ctd:C478565 | |
| Drug | buprenorphine hydrochloride solution | 2.97e-07 | 41 | 152 | 6 | CID000002476 | |
| Drug | AC1L1IMA | 2.97e-07 | 41 | 152 | 6 | CID000004639 | |
| Drug | propoxyphene | 3.20e-07 | 67 | 152 | 7 | CID000010100 | |
| Drug | AC1L2K1Q | 3.79e-07 | 23 | 152 | 5 | CID000022258 | |
| Drug | Codeine | 3.89e-07 | 10 | 152 | 4 | ctd:D003061 | |
| Drug | AC1LCF1O | 3.89e-07 | 10 | 152 | 4 | CID000627285 | |
| Drug | cyclamate | 1.08e-06 | 28 | 152 | 5 | CID000007533 | |
| Drug | Dynorphins | 1.16e-06 | 4 | 152 | 3 | ctd:D004399 | |
| Drug | AC1L5BQM | 1.16e-06 | 4 | 152 | 3 | CID000174892 | |
| Drug | Diprenorphine | 1.16e-06 | 4 | 152 | 3 | DB01548 | |
| Drug | 3B-b | 1.16e-06 | 4 | 152 | 3 | CID000533975 | |
| Drug | Naltrexone | 1.16e-06 | 4 | 152 | 3 | DB00704 | |
| Drug | Methadyl Acetate | 1.16e-06 | 4 | 152 | 3 | ctd:D008692 | |
| Drug | 7-hydroxymitragynine | 1.16e-06 | 4 | 152 | 3 | ctd:C482678 | |
| Drug | methadol | 1.30e-06 | 13 | 152 | 4 | CID000028397 | |
| Drug | cyprodime hydrobromide | 1.30e-06 | 13 | 152 | 4 | CID005748293 | |
| Drug | naltrindole-5'-isothiocyanate | 1.81e-06 | 14 | 152 | 4 | CID005487327 | |
| Drug | I06-1317 | 1.81e-06 | 14 | 152 | 4 | CID003081923 | |
| Drug | mitragynine | 2.46e-06 | 15 | 152 | 4 | ctd:C001801 | |
| Drug | norbuprenorphine | 2.53e-06 | 33 | 152 | 5 | CID000114976 | |
| Drug | Dihydromorphine | 2.89e-06 | 5 | 152 | 3 | DB01565 | |
| Drug | Naloxone | 2.89e-06 | 5 | 152 | 3 | DB01183 | |
| Drug | oxymorphamine | 2.89e-06 | 5 | 152 | 3 | CID000134844 | |
| Drug | Sc 39566 | 2.89e-06 | 5 | 152 | 3 | CID000130018 | |
| Drug | Dextromethorphan | 2.95e-06 | 34 | 152 | 5 | ctd:D003915 | |
| Drug | levo-dromoran tartrate | 4.28e-06 | 98 | 152 | 7 | CID000003918 | |
| Drug | Buprenorphine | 5.43e-06 | 18 | 152 | 4 | ctd:D002047 | |
| Drug | AC1L1QMT | 5.43e-06 | 18 | 152 | 4 | CID000008270 | |
| Drug | Etorphine | 5.75e-06 | 6 | 152 | 3 | DB01497 | |
| Drug | AC1L2OET | 5.75e-06 | 6 | 152 | 3 | CID000125331 | |
| Drug | NSC612111 | 5.75e-06 | 6 | 152 | 3 | CID000163346 | |
| Drug | Loperamide | 5.75e-06 | 6 | 152 | 3 | DB00836 | |
| Drug | RX8008M | 5.75e-06 | 6 | 152 | 3 | CID000162443 | |
| Drug | loperamide | 6.78e-06 | 105 | 152 | 7 | CID000003954 | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A | 7.94e-06 | 199 | 152 | 9 | 1383_UP | |
| Drug | NSC76436 | 8.51e-06 | 20 | 152 | 4 | CID000002828 | |
| Drug | 2',6'-dimethyltyrosine | 8.51e-06 | 20 | 152 | 4 | CID000124247 | |
| Drug | fentanyl | 9.78e-06 | 111 | 152 | 7 | CID000003345 | |
| Drug | Tyr-ala-phe-gly | 1.00e-05 | 7 | 152 | 3 | CID005487532 | |
| Drug | Enkephalin, D-Penicillamine (2,5)- | 1.00e-05 | 7 | 152 | 3 | ctd:D020881 | |
| Drug | MET-CAMO | 1.00e-05 | 7 | 152 | 3 | CID006450159 | |
| Drug | phenylmorphan | 1.00e-05 | 7 | 152 | 3 | CID000146306 | |
| Drug | AC1L9PCU | 1.00e-05 | 7 | 152 | 3 | CID000451042 | |
| Drug | N-cyclopropylmethylnorazidomorphine | 1.00e-05 | 7 | 152 | 3 | CID005489191 | |
| Drug | 2-mercaptoacetate | 1.00e-05 | 7 | 152 | 3 | ctd:C017487 | |
| Drug | Dextropropoxyphene | 1.00e-05 | 7 | 152 | 3 | ctd:D011431 | |
| Drug | AC1L2YDY | 1.00e-05 | 7 | 152 | 3 | CID000130992 | |
| Drug | beta-naltrexamine | 1.00e-05 | 7 | 152 | 3 | CID005486948 | |
| Drug | NDTMB | 1.00e-05 | 7 | 152 | 3 | CID000134748 | |
| Drug | ethosuximide | 1.02e-05 | 74 | 152 | 6 | CID000003291 | |
| Drug | dulcin | 1.05e-05 | 21 | 152 | 4 | CID000009013 | |
| Drug | acetylmethadol | 1.05e-05 | 21 | 152 | 4 | CID000010517 | |
| Drug | NSC35549 | 1.27e-05 | 22 | 152 | 4 | CID000411697 | |
| Drug | beta-CNA | 1.53e-05 | 23 | 152 | 4 | CID005486190 | |
| Drug | ICI 204448 | 1.59e-05 | 8 | 152 | 3 | CID000003683 | |
| Drug | metazocine | 1.59e-05 | 8 | 152 | 3 | CID000062518 | |
| Drug | AC1L1B1Q | 1.59e-05 | 8 | 152 | 3 | CID000001246 | |
| Drug | DIPPA | 1.59e-05 | 8 | 152 | 3 | CID000127914 | |
| Drug | Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone | 1.59e-05 | 8 | 152 | 3 | CID005492572 | |
| Drug | U 69593 | 1.59e-05 | 8 | 152 | 3 | ctd:C045444 | |
| Drug | AC1L2Y8M | 1.59e-05 | 8 | 152 | 3 | CID000130908 | |
| Drug | 14-methoxymetopon | 1.59e-05 | 8 | 152 | 3 | CID005486940 | |
| Drug | KT-89 | 1.59e-05 | 8 | 152 | 3 | CID005748450 | |
| Drug | binaltorphimine | 1.59e-05 | 8 | 152 | 3 | CID005484197 | |
| Drug | N-methyl nalorphine | 1.59e-05 | 8 | 152 | 3 | CID005748235 | |
| Drug | AC1LBBLW | 1.59e-05 | 8 | 152 | 3 | CID000579851 | |
| Drug | Oxymorphone hydrazone | 1.59e-05 | 8 | 152 | 3 | CID009577748 | |
| Drug | gamma-aminobutyric acid | CACNA1S RELN SPG7 SLC1A1 CHRNA1 RYR3 OPRD1 OPRK1 OPRM1 NEO1 CLCN6 CACNA1I ACP4 | 1.86e-05 | 474 | 152 | 13 | CID000000119 |
| Drug | Tramadol | 2.17e-05 | 25 | 152 | 4 | ctd:D014147 | |
| Drug | pimozide | 2.35e-05 | 127 | 152 | 7 | CID000016362 | |
| Drug | Dam K | 2.38e-05 | 9 | 152 | 3 | CID005487344 | |
| Disease | severe acute respiratory syndrome, COVID-19 | RELN ANXA4 SAMD5 TENM2 PREX2 NLN PTPN4 ABLIM1 MALRD1 SLC15A1 ATP11A | 1.31e-05 | 447 | 144 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | Kabuki syndrome (implicated_via_orthology) | 7.07e-05 | 3 | 144 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | Hypotension, Orthostatic | 7.07e-05 | 3 | 144 | 2 | C0020651 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 8.80e-05 | 18 | 144 | 3 | OBA_2045175 | |
| Disease | Generalized seizures | 1.40e-04 | 101 | 144 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.40e-04 | 101 | 144 | 5 | C0234535 | |
| Disease | Convulsive Seizures | 1.40e-04 | 101 | 144 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.40e-04 | 101 | 144 | 5 | C0751496 | |
| Disease | Non-epileptic convulsion | 1.40e-04 | 101 | 144 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.40e-04 | 101 | 144 | 5 | C0751123 | |
| Disease | Complex partial seizures | 1.40e-04 | 101 | 144 | 5 | C0149958 | |
| Disease | Single Seizure | 1.40e-04 | 101 | 144 | 5 | C0751110 | |
| Disease | Nonepileptic Seizures | 1.40e-04 | 101 | 144 | 5 | C3495874 | |
| Disease | Visual seizure | 1.40e-04 | 101 | 144 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.40e-04 | 101 | 144 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 1.40e-04 | 101 | 144 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.40e-04 | 101 | 144 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.40e-04 | 101 | 144 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.40e-04 | 101 | 144 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.40e-04 | 101 | 144 | 5 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.40e-04 | 101 | 144 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 1.40e-04 | 101 | 144 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 1.40e-04 | 101 | 144 | 5 | C4317109 | |
| Disease | unipolar depression, smoking behaviour measurement | 1.41e-04 | 4 | 144 | 2 | EFO_0003761, EFO_0005671 | |
| Disease | Absence Seizures | 1.47e-04 | 102 | 144 | 5 | C4316903 | |
| Disease | Convulsions | 1.47e-04 | 102 | 144 | 5 | C4048158 | |
| Disease | Tonic Seizures | 1.47e-04 | 102 | 144 | 5 | C0270844 | |
| Disease | Seizures, Focal | 1.61e-04 | 104 | 144 | 5 | C0751495 | |
| Disease | Myoclonic Seizures | 1.61e-04 | 104 | 144 | 5 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.61e-04 | 104 | 144 | 5 | C0494475 | |
| Disease | Drug habituation | 2.58e-04 | 115 | 144 | 5 | C0013170 | |
| Disease | Drug abuse | 2.58e-04 | 115 | 144 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.58e-04 | 115 | 144 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.58e-04 | 115 | 144 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 2.58e-04 | 115 | 144 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.58e-04 | 115 | 144 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.58e-04 | 115 | 144 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.58e-04 | 115 | 144 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.58e-04 | 115 | 144 | 5 | C0029231 | |
| Disease | Substance abuse problem | 2.68e-04 | 116 | 144 | 5 | C0740858 | |
| Disease | oral cavity cancer (is_implicated_in) | 3.50e-04 | 6 | 144 | 2 | DOID:8618 (is_implicated_in) | |
| Disease | X-14939 measurement | 3.50e-04 | 6 | 144 | 2 | EFO_0800747 | |
| Disease | alpha 1-antitrypsin deficiency (implicated_via_orthology) | 4.89e-04 | 7 | 144 | 2 | DOID:13372 (implicated_via_orthology) | |
| Disease | X-18899 measurement | 4.89e-04 | 7 | 144 | 2 | EFO_0800793 | |
| Disease | Cocaine Dependence | 6.15e-04 | 139 | 144 | 5 | C0600427 | |
| Disease | Epilepsy, Cryptogenic | 7.08e-04 | 82 | 144 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 7.08e-04 | 82 | 144 | 4 | C0751111 | |
| Disease | Aura | 7.08e-04 | 82 | 144 | 4 | C0236018 | |
| Disease | Seizures | 7.26e-04 | 218 | 144 | 6 | C0036572 | |
| Disease | lung adenocarcinoma (is_marker_for) | 8.11e-04 | 85 | 144 | 4 | DOID:3910 (is_marker_for) | |
| Disease | Autism Spectrum Disorders | 8.11e-04 | 85 | 144 | 4 | C1510586 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 8.33e-04 | 9 | 144 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | colorectal cancer, hormone replacement therapy | 9.23e-04 | 88 | 144 | 4 | EFO_0003961, MONDO_0005575 | |
| Disease | Congenital myasthenic syndrome | 1.04e-03 | 10 | 144 | 2 | cv:C0751882 | |
| Disease | asthma exacerbation measurement | 1.13e-03 | 93 | 144 | 4 | EFO_0007614 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.26e-03 | 11 | 144 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Respiratory Depression | 1.78e-03 | 13 | 144 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 1.78e-03 | 13 | 144 | 2 | C0035229 | |
| Disease | Respiratory Failure | 1.78e-03 | 13 | 144 | 2 | C1145670 | |
| Disease | eosinophil measurement | 1.97e-03 | 108 | 144 | 4 | EFO_0803540 | |
| Disease | Epilepsy | 2.04e-03 | 109 | 144 | 4 | C0014544 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.07e-03 | 14 | 144 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Hepatitis C | 2.38e-03 | 15 | 144 | 2 | C0019196 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.75e-03 | 195 | 144 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Withdrawal Symptoms | 2.89e-03 | 58 | 144 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.89e-03 | 58 | 144 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.89e-03 | 58 | 144 | 3 | C0038587 | |
| Disease | parental longevity | 3.02e-03 | 494 | 144 | 8 | EFO_0007796 | |
| Disease | Glycogen storage disease | 3.07e-03 | 17 | 144 | 2 | cv:C0017919 | |
| Disease | esophageal carcinoma, gastric carcinoma | 3.07e-03 | 17 | 144 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | angiopoietin-related protein 1 measurement | 3.44e-03 | 18 | 144 | 2 | EFO_0801382 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 3.83e-03 | 19 | 144 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | fatty acid measurement, linoleic acid measurement | 4.52e-03 | 68 | 144 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.87e-03 | 139 | 144 | 4 | DOID:3908 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFMQRVKNMLYPLAL | 206 | P35503 | |
| LGMATAYMILKQTPR | 1161 | Q7Z4L5 | |
| DVPLIGKYLMFTMVL | 291 | P30926 | |
| SGPNSRLYMKLVMRI | 581 | Q9BSJ8 | |
| VYMKGAPEMVARFCR | 621 | Q4VNC0 | |
| DRIYNMLRMFVVTGP | 771 | Q9UJX6 | |
| FYIGTQLMERLKPSM | 831 | O43683 | |
| FPYEMLMVTNRGRNK | 716 | O14639 | |
| LRKPGAQIYMRFMQE | 176 | Q9UGI9 | |
| IRKMGNKPHMIQVYR | 291 | Q9HD20 | |
| KPYVGLMADSVRVML | 156 | Q02928 | |
| GSYSLRAVQMMIKPI | 476 | O95841 | |
| VMIVLAFIILNYGPM | 381 | P18850 | |
| FEQVIVGMMTPTVLY | 76 | P09525 | |
| PVFTLYVGSQRMVVM | 66 | P05181 | |
| VMSGGILIYKNRVRM | 236 | P29074 | |
| VPLIGKYMLFTMVFV | 291 | P02708 | |
| DKMASVFYTVIIPML | 271 | P0C7N1 | |
| IRVTVIPFYMGMREA | 241 | Q9Y2S7 | |
| VSYIPFHVMKTMNLR | 271 | P47900 | |
| FQNLLQGRMYKMVIV | 1141 | P23467 | |
| VKMMYLGVGVFSLPL | 196 | Q9Y585 | |
| NYPVIMNRGVFMKLV | 131 | P58181 | |
| GLPVMFMATTKYRQG | 201 | P35372 | |
| DKAVAVFYTMVVPML | 266 | Q96R67 | |
| MGKRDNRVAYMNPIA | 1 | Q8N9E0 | |
| LIAMLPLVGVSNYMK | 496 | P22888 | |
| NGMVGLVPKNYVTVM | 236 | P16333 | |
| VESMKYPFRQGMRLE | 316 | Q969R5 | |
| KVMPNMYRVGVSKLF | 1871 | Q9UKN7 | |
| ILGMNTVQLYMKVPG | 1126 | O15550 | |
| MFIPKGVVVMIPSYA | 386 | P08684 | |
| KFLNEMIAPVMRVNY | 211 | Q9UHG3 | |
| KLDFLVNIYMQRMGI | 636 | O43526 | |
| MVVVMNFPYCGLRKV | 161 | Q96R30 | |
| PKMEMILSGVVAIFY | 21 | Q9Y3N9 | |
| VLNPVIYTFRNKEMM | 281 | Q8NGB9 | |
| DKMVAVFYTIITPML | 266 | Q8NH73 | |
| VFVLYELSPMMVKLT | 321 | Q9Y282 | |
| MPALMRVGIFQSFQK | 431 | Q9NUL7 | |
| VLFRTVAMMVPNYAL | 1371 | Q6ZR08 | |
| KLMGVVPVSYFIRNM | 91 | Q0VAA2 | |
| VKMYATIPELGVQVM | 5026 | P98088 | |
| VYQVAKMINLMRPGV | 2251 | P23471 | |
| LMYLCVTVPKMLVGQ | 76 | Q8NGX1 | |
| LMYLCVTVPKMLVGQ | 76 | Q8NH03 | |
| EKVVSMFYTLGIPML | 271 | Q8NH18 | |
| IIYPMKNHMFFIAIT | 1771 | Q2PPJ7 | |
| DKMASVFYTVIIPML | 271 | P0C7N5 | |
| MVAVAKPMVYITVGE | 1271 | Q86VI3 | |
| ELIIQPGYMMQFKIV | 3111 | P78509 | |
| MKIMVYKIFRILVPG | 141 | Q9BUE0 | |
| MKVASIFYGTVIPML | 271 | Q8NH89 | |
| GNVLVMFGIVRYTKM | 66 | P41143 | |
| LPVMYLMDSIVKNVG | 71 | O94913 | |
| PQYMRYVIKGGMIII | 181 | Q14973 | |
| SRVQRLGLPLKMVMY | 271 | Q9BZG2 | |
| MKVAFIFYGTVIPML | 271 | Q8NH90 | |
| MIDPRSMGILKVYTI | 1816 | Q5VYJ5 | |
| VVYTMLPFNMRDAII | 146 | Q08462 | |
| INVVLVRMIMLGYAK | 301 | O15072 | |
| ITYGLPIMVTLMVAK | 551 | P51797 | |
| TIRMMENGIKPVYVF | 71 | P39748 | |
| MGKRDNRVAYMNPIA | 1 | Q5BKY9 | |
| YLMSGVMAPVKRRNV | 576 | Q9HCG7 | |
| RTMGVMFTPLTVKYA | 226 | O00303 | |
| YAVIGMQMFGKIALV | 1281 | Q13698 | |
| IVDSKYFNRGIMMAI | 636 | Q9P0X4 | |
| KPYVGLMADSVRVML | 156 | Q5TCH4 | |
| KPYVAMVTTYQMAVL | 571 | Q13617 | |
| PLKSIYMRQIDQMVG | 641 | Q92611 | |
| QFYQLKLPMVTVAMA | 261 | Q96A59 | |
| VMRLVKGMNFSVVVF | 151 | O43681 | |
| PMKITGNRAVMALVY | 136 | Q8N6U8 | |
| PFAYCMMIRVASKQL | 226 | Q9Y678 | |
| PYVVQSIISLIMGMK | 261 | Q5TBA9 | |
| QMKAFPRIVRESYAM | 6561 | Q8NDH2 | |
| FRYKLLRAGGVMVMP | 131 | Q03111 | |
| MTVNRQMKRYNVPFL | 156 | Q96RP9 | |
| MPAKFVRCAYVIILM | 31 | Q86YT5 | |
| QIKMVTRVMFLYIPL | 276 | P46059 | |
| FIVVRKNPFRFAMGM | 306 | P43005 | |
| GLQMPVVVQSMYIFK | 131 | Q5SRE7 | |
| MFPLQMIYLVVKAAV | 11 | O75911 | |
| YMMIDGVFRGNPKQV | 371 | Q93100 | |
| PVQMMYLREKLNIGY | 231 | P05120 | |
| TLMKAYGIRFDVMVN | 311 | Q93086 | |
| VKMMYLGVGIFSVPL | 196 | Q9P1Q5 | |
| FRPLSMYSVMKGRVA | 261 | Q8NGR5 | |
| GNSLVMFVIIRYTKM | 76 | P41145 | |
| RYPVIMSKGAYVAMA | 131 | Q8NGS7 | |
| HYKRILTPQVMLGMS | 161 | Q8NH67 | |
| YVMIFRAVMGLATPE | 221 | Q8NGK5 | |
| QDMMSYIGPKRTAVV | 156 | Q96S52 | |
| DKMASVFYTVIIPML | 271 | Q8NH10 | |
| RPMYLAMRQFKKAVT | 246 | Q86TM6 | |
| YMVRIISKAPCMVLR | 651 | Q5T011 | |
| MNTVQLYMKVPGSRT | 1076 | O14607 | |
| LVPGKYVMVMGVVQA | 96 | Q96E14 | |
| PAIGMIIYFARKANM | 711 | P19320 | |
| SDGIPMYKRNVMILT | 81 | Q9UGI8 | |
| MYKRNVMILTNPVAA | 86 | Q9UGI8 | |
| AFVEGVKMRTYKPLM | 401 | Q9BZE2 | |
| VGMVTIIMNDYPKFK | 161 | Q9BY50 | |
| YLRSVMNKVIQMVPE | 741 | Q8TEQ0 | |
| PVIFLVQASGMNVYM | 201 | Q6P4A7 | |
| SRKVPMAGILEYLMN | 151 | Q5TGI4 | |
| YPKLMSIMGNVLRFL | 111 | Q9NXC2 | |
| PYLRGTIKMMQAVRQ | 301 | Q9NXC2 | |
| FCGILYMKPRMKIFL | 271 | Q8TE76 | |
| QNLMPATVYIFRVMA | 501 | Q92859 | |
| RAQIMAYKMLARGQP | 181 | P51532 | |
| LMTKTYIPILAFTQM | 116 | Q5SWH9 | |
| MPYSTNKELILGIMV | 1 | Q96LZ7 | |
| NGLMYFVDATMIRKV | 1366 | Q9NT68 | |
| KMVAVFYTTVIPMLN | 271 | Q8NGP6 | |
| IAGMITVAYPQMKLK | 231 | O75192 | |
| VVFGRPRLALMYRMQ | 201 | Q9UQ90 | |
| DKMASVFYTVVIPML | 271 | Q8NH85 | |
| GISVYVIFIPVQMFM | 266 | Q96J65 | |
| MIVCVDKRLQSPMYF | 46 | Q8NGU2 | |
| IKRAQIMGFMPVTYK | 111 | Q9Y3D5 | |
| VKMMTQKGLYRIGFI | 221 | Q96P63 | |
| VKVPMMFRSGIYQVG | 236 | Q8IW75 | |
| QDVARMMYVVFKEVP | 251 | A8MXE2 | |
| LFAFVIKMPVMYRIG | 556 | O96005 | |
| MGFAILNMIQVPYRA | 116 | A0PK11 | |
| PVSMYVTVEMQKFLG | 361 | P98196 | |
| IMNPEVGMKYRNLIL | 656 | Q9BYT8 | |
| IEPTMVVQGVKMLYV | 981 | A0AVT1 | |
| PHLMSIFKGRMVVYQ | 486 | P09327 | |
| GMLKYIRLQVMSLSP | 1556 | Q8N2C7 | |
| APGYHMAKMIIRLVT | 611 | P11217 | |
| KVFYQHPNLMRVLGM | 2051 | Q15413 | |
| NPYSRLMALKRMGIV | 51 | Q9GZZ9 | |
| FKEMMRFIYTGRAPN | 251 | Q6IQ16 | |
| RNPYLVAKLVEVMFM | 926 | O95155 | |
| AAVYAKMMGIPIRKF | 516 | Q8IYQ7 | |
| PRYIMQATDVMRKQG | 1556 | Q70Z35 | |
| YVVRLMAPFNMRCKT | 31 | Q9BW85 | |
| AYLRMQGFVESMKII | 176 | P49746 | |
| QGPYVSMAFITVLKM | 676 | Q8TE23 | |
| YMILYITGRPDMQKQ | 776 | Q9BZ71 | |
| MPVRYFIMKSSNLRN | 1286 | Q9H6S0 | |
| GLFVEKMPARIYQMV | 2106 | Q9UPU5 | |
| EYMVNTFIVMQRKLG | 1241 | O60346 | |
| MRGLYRGIAPNFMKV | 431 | Q9BV35 | |
| FKGSQGYLVVRLSMM | 671 | O94901 | |
| EMIITKAGRRMFPSY | 86 | P57082 | |
| GRRMFPTFQVKLFGM | 136 | O43435 | |
| SPGMVLMQRAKLYLE | 396 | Q9H8Y1 | |
| YARYLKMVQVGVPVM | 136 | Q9Y3C0 | |
| TAQTFIYPMEVMKTR | 301 | Q6NUK1 | |
| PFTGYIIAVHRKMMR | 1071 | Q8NFA0 | |
| MEMVGFLPKTRRQIF | 406 | B2RTY4 | |
| FIRPFYKMMLGKQIT | 731 | Q96PU5 |